HomeCompareCVET vs XYLD

CVET vs XYLD: Dividend Comparison 2026

CVET yields 9.53% · XYLD yields 10.98%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CVET wins by $12.3K in total portfolio value
10 years
CVET
CVET
● Live price
9.53%
Share price
$20.99
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$37.6K
Annual income
$1,735.75
Full CVET calculator →
XYLD
Global X S&P 500 Covered Call ETF
● Live price
10.98%
Share price
$39.13
Annual div
$4.30
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25.3K
Annual income
$3,219.02
Full XYLD calculator →

Portfolio growth — CVET vs XYLD

📍 CVET pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCVETXYLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CVET + XYLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CVET pays
XYLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CVET
Annual income on $10K today (after 15% tax)
$809.91/yr
After 10yr DRIP, annual income (after tax)
$1,475.39/yr
XYLD
Annual income on $10K today (after 15% tax)
$933.63/yr
After 10yr DRIP, annual income (after tax)
$2,736.17/yr
At 15% tax rate, XYLD beats the other by $1,260.78/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CVET + XYLD for your $10,000?

CVET: 50%XYLD: 50%
100% XYLD50/50100% CVET
Portfolio after 10yr
$31.4K
Annual income
$2,477.38/yr
Blended yield
7.88%
📊

Analyst Conviction Gap

Where Wall Street is split right now

CVET
Analyst Ratings
1
Hold
Consensus: Hold
XYLD
No analyst data
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CVET buys
0
XYLD buys
0
No recent congressional trades found for CVET or XYLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCVETXYLD
Forward yield9.53%10.98%
Annual dividend / share$2.00$4.30
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$37.6K$25.3K
Annual income after 10y$1,735.75$3,219.02
Total dividends collected$13.4K$19.6K
Payment frequencyquarterlymonthly
SectorStockETF

Year-by-year: CVET vs XYLD ($10,000, DRIP)

YearCVET PortfolioCVET Income/yrXYLD PortfolioXYLD Income/yrGap
1← crossover$11,653$952.83$10,818$1,098.39+$835.00CVET
2$13,506$1,037.68$11,738$1,222.51+$1.8KCVET
3$15,576$1,124.05$12,774$1,364.64+$2.8KCVET
4$17,877$1,211.47$13,944$1,527.86+$3.9KCVET
5$20,428$1,299.54$15,270$1,715.87+$5.2KCVET
6$23,246$1,387.82$16,775$1,933.09+$6.5KCVET
7$26,349$1,475.94$18,490$2,184.87+$7.9KCVET
8$29,757$1,563.52$20,450$2,477.63+$9.3KCVET
9$33,491$1,650.22$22,697$2,819.19+$10.8KCVET
10$37,571$1,735.75$25,280$3,219.02+$12.3KCVET

CVET vs XYLD: Complete Analysis 2026

CVETStock

Covetrus, Inc., together with its subsidiaries, operates as an animal-health technology and services company. It engages in the sale of animal-health consumable products, including proprietary and Covetrus branded products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, parasiticides, and vitamins and supplements to wholesale and retail customers. The company also offers value-added solutions, such as inventory management and e-commerce, as well as continuing education services for practitioners. In addition, it provides practice management software, data-driven applications, client communications tools, and related services to increase staff efficiency and enhance business health; and solutions that integrate with its software platforms, including client communication services, reminders, data backup services, hardware sales and support, and credit card processing services for veterinary practitioners and animal-health clinics. Further, the company engages in the distribution of finished goods pharmacy and specialty pharmaceutical compounding products, as well as offers shipping, manufacturer incentives, service fees, and data integration and support services. It serves animal-health and veterinary practices, and clinics in the companion-animal, equine, and large-animal markets primarily in North America, Europe, and the Asia Pacific. The company was formerly known as HS Spinco, Inc. Covetrus, Inc. was incorporated in 2018 and is headquartered in Portland, Maine. As of October 13, 2022, Covetrus, Inc. was taken private.

Full CVET Calculator →

XYLDETF

The Global X S&P 500 Covered Call ETF (XYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe S&P 500 BuyWrite Index.

Full XYLD Calculator →
📬

Get this CVET vs XYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CVET vs SCHDCVET vs JEPICVET vs OCVET vs KOCVET vs MAINCVET vs QYLDCVET vs JEPQCVET vs RYLD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.